Europe Central Lab Market Size & Outlook, 2025-2030

The central lab market in Europe is expected to reach a projected revenue of US$ 1,442.3 million by 2030. A compound annual growth rate of 6.9% is expected of Europe central lab market from 2025 to 2030.
Revenue, 2024 (US$M)
$970.8
Forecast, 2030 (US$M)
$1,442.3
CAGR, 2025 - 2030
6.9%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe central lab market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe central lab market highlights

  • The Europe central lab market generated a revenue of USD 970.8 million in 2024.
  • The market is expected to grow at a CAGR of 6.9% from 2025 to 2030.
  • In terms of segment, biomarker services was the largest revenue generating services in 2024.
  • Genetic Services is the most lucrative services segment registering the fastest growth during the forecast period.
  • Country-wise, France is expected to register the highest CAGR from 2025 to 2030.


Europe data book summary

Market revenue in 2024USD 970.8 million
Market revenue in 2030USD 1,442.3 million
Growth rate6.9% (CAGR from 2025 to 2030)
Largest segmentBiomarker services
Fastest growing segmentGenetic Services
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationGenetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services
Key market players worldwideLabConnect, Eurofins Scientific SE, A. P. Moller Maersk A/S ADR, ACM Global, Cerba Research, Synevo Central Labs, Versiti, Cenetron, Ampersand Capital Partners, Pacific Biomarkers, Cirion


Other key industry trends

  • In terms of revenue, Europe region accounted for 28.0% of the global central lab market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,201.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Central Lab Market Companies

Name Profile # Employees HQ Website
Cirion View profile 101-250 Laval, Quebec, Canada, North America https://www.cirion.com
Pacific Biomarkers View profile 51-100 Seattle, Washington, United States, North America http://www.pacbio.com
Ampersand Capital Partners View profile 11-50 Wellesley, Massachusetts, United States, North America http://www.ampersandcapital.com
Cenetron View profile 101-250 Austin, Texas, United States, North America https://www.cenetron.com/
Versiti View profile 1001-5000 Milwaukee, Wisconsin, United States, North America https://www.versiti.org/
Synevo Central Labs View profile - Waterloo, Brabant Wallon, Belgium, Europe http://www.synevo-centrallabs.eu
Cerba Research View profile 5001-10000 Ghent, Oost-Vlaanderen, Belgium, Europe https://www.cerbaresearch.com
ACM Global View profile 251-500 Rochester, New York, United States, North America http://www.acmgloballab.com
LabConnect View profile 101-250 Johnson City, Tennessee, United States, North America https://www.labconnect.com/
A. P. Moller Maersk A/S ADR View profile 100000 Esplanaden 50, Copenhagen, Denmark, 1263 https://www.maersk.com
Eurofins Scientific SE View profile 61798 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 https://www.eurofins.com

Europe central lab market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central lab market will help companies and investors design strategic landscapes.


Biomarker services was the largest segment with a revenue share of 41.1% in 2024. Horizon Databook has segmented the Europe central lab market based on genetic services, biomarker services, microbiology services, anatomic pathology/histology, specimen management & storage, special chemistry services covering the revenue growth of each sub-segment from 2018 to 2030.


Europe accounts for a significant revenue share of central lab market due to the presence of developed economies, such as Germany, Spain, the UK, France, and Italy. These countries have an advanced laboratory infrastructure, which is anticipated to significantly boost clinical research prospects in the region. 

Furthermore, growing trend of personalized medicine is projected to further accelerate the market growth. The increasing prevalence of genetic disorders and infectious diseases, coupled with growing investments in genomic research initiatives, is expected to drive the market. 

However, uneven reimbursement policies may restrain the market growth. Europe became the focal point of the COVID-19 pandemic in early March 2020, with the virus spreading rapidly across the region. 

Reasons to subscribe to Europe central lab market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe central lab market databook

  • Our clientele includes a mix of central lab market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe central lab market , including forecasts for subscribers. This continent databook contains high-level insights into Europe central lab market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe central lab market size, by country, 2018-2030 (US$M)

Europe Central Lab Market Outlook Share, 2024 & 2030 (US$M)

Europe central lab market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online